East Side Oncology Associates Pllc is categorized under Oncologists in New York City, NY and active since 2007.
East Side Oncology Associates Pllc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Robert Gelfand at the company’s single location by writing to 142 East 81st St, New York City, New York NY 10028 or by phoning (212) 879-3496. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | East Side Oncology Associates Pllc |
| Contact Person: | Robert Gelfand |
| Address: | 142 East 81st St, New York City, New York 10028 |
| Phone Number: | (212) 879-3496 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
East Side Oncology Associates Pllc was started in 2007 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Robert Gelfand for inquiries that concern East Side Oncology Associates Pllc by calling the company number (212) 879-3496, as your correspondence is most welcome. Additionally, the physical location of the single location of East Side Oncology Associates Pllc can be found at the coordinates 40.776055,-73.957779 as well as the street address 142 East 81st St in New York City, New York 10028.
For its online presence, you may visit East Side Oncology Associates Pllc’s website at and engage with its social media outlets through on Twitter and on Facebook.